1 Min Read
July 3 (Reuters) - CORLINE BIOMEDICAL AB:
* SIGNS LETTER OF INTENT WITH UNIVERSITY OF ALBERTA IN CANADA REGARDING THE COMPANY‘S CLINICAL STUDY IN TYPE 1 DIABETES Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.